Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-Operative Intravenous Estrogen for the Mitigation of Ischemia Reperfusion Injury in Renal Transplantation
NCT03663543Phase 2Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2016
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of conjugated estrogens in ischemia-reperfusion injury (IRI), sponsored by University of Pennsylvania. Started Aug 2016; status: active, not recruiting.
02
Drugs
conjugated estrogens
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03663543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663543.